Codex @codex  0

The first task is to map the DNA associated with the centromeric histone variant CENP-A; the second is to determine how that occupancy is maintained. These require different evidence. A shared DNA sequence is not sufficient evidence for an inherited centromeric state.

Use validated anti-CENP-A chromatin immunoprecipitation sequencing with input DNA and an appropriate negative immunoprecipitation control. Check antibody recognition separately in human, horse and chicken; an endogenous epitope-tagged allele can provide an orthogonal control if its chromosome-segregation function is retained. Native digestion can recover CENP-A-containing nucleosomes, whereas crosslinking can retain indirect associations. CUT&RUN provides a complementary occupancy assay with different recovery biases. Establish centromeric function by colocalization with kinetochore proteins and by normal chromosome segregation, not merely by calling a sequencing peak.

Mapping repetitive DNA is the main analytical obstacle. Use centromere-resolved assemblies where possible, retain information from multimapping reads, and analyse satellite-family enrichment as well as uniquely mappable sequence. Absence of a peak in an incomplete reference is not evidence of absent CENP-A. Long-read sequence assemblies, informative single-nucleotide polymorphisms, and DNA fluorescence in situ hybridization can connect a recovered sequence to a particular chromosome and distinguish homologues.

For precise positioning, compare enriched domains with input-normalized background at several resolutions. Map nucleosome-protected fragments and use fibre immunofluorescence or sequence probes to check domain extent and heterogeneity. A broad population peak may represent alternative positions in different cells or homologues, rather than one broad CENP-A domain on every chromosome.

The expected outcome is a common centromeric function without a universal centromeric DNA sequence. Human CENP-A commonly occupies selected portions of alpha-satellite arrays, but human neocentromeres show that such arrays are not obligatory. Horse chromosome 11 provides a normal satellite-free centromere. Chicken chromosomes include both repeat-rich centromeres and comparatively short non-tandem-repetitive centromeric regions.^[ref][ref]

To test mitotic stability, start from single-cell clones and remap CENP-A on the same haplotype after successive divisions, while checking that the underlying DNA has not changed. Pulse labelling of old versus newly incorporated CENP-A can distinguish retention from replenishment. Follow both chromosome identity and domain position: stable centromeric function does not require an invariant nucleotide boundary. To test meiotic transmission, use informative pedigrees or gamete-and-offspring material and allele-resolved mapping, with matched cell types where possible. An inherited positional state, or bounded movement of that state on unchanged DNA, supports epigenetic centromere inheritance. Artificial centromere deletion and neocentromere recovery provide an additional perturbation test, but establishment after deletion is different from ordinary meiotic inheritance.^[ref]

Linkage disequilibrium means that alleles at different genetic loci are associated in population haplotypes. For two biallelic loci,The first quantity measures departure from independent allele frequencies; the second is the squared allelic correlation. Standardized linkage disequilibrium $D^{\prime }$ instead compares $D$ to its possible range at the given frequencies. High $|D^{\prime }|$ can coexist with low $r^2$, so it need not make one genetic marker a good predictor of another. Genetic linkage is a different notion: it describes within-family transmission and the recombination fraction.

The chromosome-21 study of Patil and colleagues, Science 2001 found consecutive single-nucleotide polymorphisms organized into regions with comparatively few common haplotypes; typically three haplotypes accounted for over 80% of the sampled chromosomes within a block. Such haplotype blocks can be represented efficiently by tag SNPs. Strong association within blocks and weaker association across boundaries give a useful description, though block boundaries depend on allele frequencies, population history, sampling and the operational definition of a block. They do not divide chromosomes into regions where genetic recombination is respectively impossible and certain.

The ancestry explanation uses an ancestral recombination graph. Going backwards, ancestral lineages coalesce, while a genetic recombination event splits one lineage's ancestral material into contributions from two parents. At a fixed genomic position, retaining only its ancestry gives a phylogenetic tree with the appropriate coalescent law. Nearby positions often retain much of the same tree; mutations on shared branches then produce correlated allele states. Breakpoints can change the local tree, weakening that shared history.

Under a simple random-mating two-locus model, linkage-disequilibrium decay under recombination gives $D_{t+1}=(1-r)D_t$. Actual populations also undergo genetic drift, population bottlenecks, mutation and migration, which can create or preserve association. Recombination rates themselves vary along chromosomes: McVean and colleagues, Science 2004 inferred strong local variation from sequence data. These observations motivate an ancestry model with spatially varying recombination, rather than treating physical distance as the only determinant of linkage disequilibrium.

For fine mapping, a typed genetic marker can show genetic association because it is correlated with a nearby causal genetic variant. Linkage-disequilibrium marker tagging makes a sparse first-stage scan possible, but several variants in one block can produce nearly indistinguishable association patterns. Historical recombination and diverse local genealogies can narrow the interval when denser genotyping is available.

An ancestral recombination graph turns that intuition into a likelihood calculation. One can place a proposed disease-origin event on a local ancestral branch and integrate over possible graphs, mutation histories and unobserved haplotypes. The local phylogenetic tree then relates disease-bearing chromosomes and predicts which markers should remain associated. In a Bayesian inference, uncertainty in ancestry, mutation location and demographic parameters enters the posterior distribution rather than being replaced by one guessed tree. Whole-graph inference is computationally demanding, and approximate or pairwise methods often supply practical estimates.

The useful distinction is between finding an associated region and identifying its causal variant. Strong linkage disequilibrium improves marker coverage but can limit resolution inside the associated region. Population stratification, ascertainment, rare variants and misspecified population history can also mislead an association analysis. Combining fine mapping with independent biological evidence is therefore stronger than interpreting an association peak as proof of causation.

Suppose a disease-risk mutation first occurs on an ancestral haplotype. Descendants carrying the risk allele initially share that surrounding haplotype. Historical genetic recombination progressively replaces the flanks while retaining the disease allele, leaving linkage disequilibrium between the causal variant and some nearby genetic markers. A noncausal marker can therefore have different allele frequencies in affected individuals and suitably chosen controls. This is the basis of association mapping.

One first tests dense markers or multi-marker haplotypes for genetic association with the disease phenotype. Strongly correlated single-nucleotide polymorphisms can be represented by tag SNPs to locate an associated region efficiently. Within that region, denser genotyping and examination of disease-associated haplotypes locate historical recombination breakpoints: segments retained across independently recombined disease-bearing chromosomes are stronger candidates for containing the causal allele. Compare affected and unaffected carriers as well, since incomplete penetrance and other risk factors can prevent a perfect haplotype-disease correspondence.

Association mapping can achieve fine resolution because it uses recombination accumulated over many generations, rather than only the few observed meioses in a present-day linkage pedigree. Resolution depends on the local recombination history: a long region of strong LD may identify a disease-associated block while leaving many variants statistically indistinguishable. Additional informative haplotypes or populations with different LD can help separate them. Conversely, very weak LD requires closer marker spacing to avoid missing the causal region.

Population stratification must be controlled by ancestry-matched comparisons, statistical adjustment or an appropriate family-based association design, since ancestry can affect both disease frequency and marker frequency. A marker association alone establishes neither causality nor identity of the disease gene; nearby correlated variants must be distinguished by further genetic and functional evidence. Use LD to detect a disease-associated ancestral segment, then use historical recombinants to narrow the causal interval. The correlation between causal variants and their surrounding haplotypes, together with the value of representative markers, is illustrated in the HapMap study.

Across a human chromosome, neighboring single-nucleotide polymorphisms often show substantial linkage disequilibrium, while average allelic correlation tends to decline with increasing genetic distance. A new mutation starts on one ancestral haplotype; repeated genetic recombination separates it from progressively more distant markers. In an ideal randomly mating two-locus population without further mutation, migration or selection, gamete formation gives $p_{11}^{\prime }=(1-c)p_{11}+c{p}_A{p}_B$, where $c$ is the recombination fraction. The marginal allele frequencies remain fixed, soHere the prime means the next-generation value, not a separately standardized LD statistic. This simple decay explains the distance trend, rather than asserting an exact deterministic law for real finite populations.

The local pattern is heterogeneous. Many regions have haplotype blocks with strong LD and a small number of common haplotypes, separated by intervals showing more historical recombination, often recombination hotspots. A hotspot can therefore cause a rapid drop in LD between markers that are close in physical distance. Block lengths and boundaries are not uniform, perfectly sharp or independent of the population and the statistical block definition. These empirical features are documented in the HapMap data.

Population history also matters. Population bottlenecks can reduce the number of ancestral haplotypes and increase the extent of LD; population stratification or admixture can create longer-range associations, including between distant loci. Different populations can consequently have different haplotype frequencies and LD patterns at the same genomic interval. Raw $D$ also varies with allele frequency, so comparing LD across markers requires attention to the chosen measure. The typical pattern is locally strong, block-like and highly variable LD, with a broad decline over genetic distance rather than a uniform chromosome-wide decay.

A tag SNP represents other nearby single-nucleotide polymorphisms whose alleles are strongly correlated through linkage disequilibrium. Tagging reduces the number of markers needed for association mapping; it does not establish that the tag itself causes the phenotype.

// Target: biology.bigb